Published in Gene Therapy Weekly, April 24th, 2003
Dr. Abel Moreyra, MD, director of the Heart Center of New Jersey, administered a one-time, intracoronary injection by heart catheterization, giving the patient either Ad5FGF-4 or a placebo. In this double-blind study, neither Moreyra nor the patient knew whether the injection contained the investigational gene therapy product or the placebo.
After receiving the injection, the patient will be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.